SCHEMBL18926478

SCHEMBL18926478

c1ccc2c(c1)nnn2-c1ccc2c(c1)CC1(CC1)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ KCNMA1 Q12791 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ MAPT P10636 4/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ CYP4Z1 Q86W10 1/20 0.40
▸ NPC1 O15118 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TNKS O95271 1/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SLC9A1 P19634 2/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21654381 0.94 SMN1; SMN2 (0.37) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL822777 0.78 SMN1; SMN2 (0.44) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL12204565 0.76 SMN1; SMN2 (0.62) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL24592756 0.74 HTR6 (0.43) SMN1; SMN2RAB9A
SCHEMBL12204569 0.74 RAB9A (0.56) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL21042484 0.73 KCNMA1 (0.40) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL24511925 0.73 MAOA (0.47) SMN1; SMN2RAB9AKCNMA1TSHRSLC9A1
SCHEMBL17355202 0.73 TNKS (0.37) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL16230166 0.73 TNKS (0.37) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT
SCHEMBL26892187 0.73 TNKS (0.39) SMN1; SMN2RAB9AKCNMA1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176172-A1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS Astrazeneca AB (SE) 2017-06-07 — — EP disclosed
Send feedback